Volume 8, Issue 3 pp. 223-228
Research Article
Full Access

Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome

Fay Katz

Fay Katz

Molecular Immunology and Molecular Genetics Units, Institute of Child Health, London WC1N 1EH, United Kingdom

Search for more papers by this author
Steve Hinshelwood

Steve Hinshelwood

Molecular Immunology and Molecular Genetics Units, Institute of Child Health, London WC1N 1EH, United Kingdom

Search for more papers by this author
Paul Rutland

Paul Rutland

Molecular Immunology and Molecular Genetics Units, Institute of Child Health, London WC1N 1EH, United Kingdom

Search for more papers by this author
Alison Jones

Alison Jones

Molecular Immunology and Molecular Genetics Units, Institute of Child Health, London WC1N 1EH, United Kingdom

Search for more papers by this author
Christine Kinnon

Corresponding Author

Christine Kinnon

Molecular Immunology and Molecular Genetics Units, Institute of Child Health, London WC1N 1EH, United Kingdom

Molecular Immunology and Molecular Genetics Units, Institute of Child Health, London WC1N 1EH, United Kingdom; Fax: 44-171-831-4366Search for more papers by this author
Gareth Morgan

Gareth Morgan

Molecular Immunology and Molecular Genetics Units, Institute of Child Health, London WC1N 1EH, United Kingdom

Search for more papers by this author

Abstract

Mutations in the gene encoding CD40 ligand have been shown to be the cause of X-linked hypogammaglobulinemia with hyper IgM (HIGM1). We have used the technique of single strand conformational polymorphism (SSCP) analysis to screen for mutations in this gene in affected boys from nineteen unrelated families. Sixteen novel mutations were identified in patients, comprising six patients with single base substitutions, two patients with single base insertions, six patients with deletions ranging from one to seven bases and two patients with large deletions at the 5′ end of the gene. These mutations were distributed throughout the gene. SSCP band shifts and/or alterations in restriction enzyme digestion sites could be used for unambiguous determination of carrier status in at-risk female relatives of most of the affected boys and, in some cases, prenatal diagnosis also can be offered. © 1996 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.